Literature DB >> 2785532

Epidermal growth factor (EGF) in human preovulatory follicles.

L G Westergaard1, C Y Andersen.   

Abstract

Concentrations of epidermal growth factor (EGF), progesterone (P4) and oestradiol (E2) were determined in follicular fluid (FF) aspirated from 69 preovulatory follicles in 15 women undergoing ovarian hyperstimulation and ovulation induction as part of IVF-ET treatment for infertility. Sixty-nine oocytes were obtained from these FF aspirates and 35 (51%) fertilized and cleaved in vitro. Pregnancy was achieved in five (33%) of the women. Concentrations of EGF in FF ranged between 0.60 and 2.42 ng/ml, corresponding to approximately 50% of the level in serum at the time of follicle aspiration. A significant linear correlation between levels of EGF in FF and in serum was demonstrated. By contrast, no significant relationships were found between intrafollicular levels of EGF and those of P4 and E2, or between EGF in FF and oocyte cleavage rate in vitro and the achievement of pregnancy after ET. It is concluded that EGF in FF of the human preovulatory follicles reflects a passive diffusion into the follicle from the circulation. Moreover, that intrafollicular EGF is not involved in the local regulation of human preovulatory follicle and oocyte maturation. These results, however, do not preclude an auto- and/or paracrine role of intrafollicular EGF in smaller human follicles.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2785532     DOI: 10.1093/oxfordjournals.humrep.a136883

Source DB:  PubMed          Journal:  Hum Reprod        ISSN: 0268-1161            Impact factor:   6.918


  9 in total

1.  IGF-I and epidermal growth factor levels in follicular fluid of women undergoing controlled ovarian hyperstimulation using the multidose GnRH-antagonist protocol or the long GnRH-agonist protocol.

Authors:  B Asimakopoulos; B Schöpper; A Dawson; G S Caglar; I Vakalopoulos; S Al-Hasani; K Diedrich; N Nikolettos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

2.  Basal p21 controls population heterogeneity in cycling and quiescent cell cycle states.

Authors:  K Wesley Overton; Sabrina L Spencer; William L Noderer; Tobias Meyer; Clifford L Wang
Journal:  Proc Natl Acad Sci U S A       Date:  2014-09-29       Impact factor: 11.205

Review 3.  Novel signaling mechanisms in the ovary during oocyte maturation and ovulation.

Authors:  Marco Conti; Minnie Hsieh; A Musa Zamah; Jeong Su Oh
Journal:  Mol Cell Endocrinol       Date:  2011-11-12       Impact factor: 4.102

4.  Comparison of follicular fluid amphiregulin and EGF concentrations in patients undergoing IVF with different stimulation protocols.

Authors:  Nana Liu; Yanmin Ma; Rong Li; Hongyan Jin; Min Li; Xiang Huang; Huai L Feng; Jie Qiao
Journal:  Endocrine       Date:  2012-06-08       Impact factor: 3.633

5.  Human oocyte maturation is dependent on LH-stimulated accumulation of the epidermal growth factor-like growth factor, amphiregulin.

Authors:  A M Zamah; M Hsieh; J Chen; J L Vigne; M P Rosen; M I Cedars; M Conti
Journal:  Hum Reprod       Date:  2010-08-18       Impact factor: 6.918

6.  Epidermal growth factor (EGF) receptor localization in cultured human granulosa lutein cells and the stimulation of progesterone production by EGF and transforming growth factor-alpha (TGF-alpha).

Authors:  F R Tekpetey; S A Daniel; A Yuzpe
Journal:  J Assist Reprod Genet       Date:  1995-11       Impact factor: 3.412

Review 7.  Epidermal growth factor-like growth factors in the follicular fluid: role in oocyte development and maturation.

Authors:  Minnie Hsieh; A Musa Zamah; Marco Conti
Journal:  Semin Reprod Med       Date:  2009-02-05       Impact factor: 1.303

Review 8.  Extra- and intra-ovarian factors in polycystic ovary syndrome: impact on oocyte maturation and embryo developmental competence.

Authors:  Jie Qiao; Huai L Feng
Journal:  Hum Reprod Update       Date:  2010-07-16       Impact factor: 15.610

Review 9.  Luteinizing Hormone Action in Human Oocyte Maturation and Quality: Signaling Pathways, Regulation, and Clinical Impact.

Authors:  Armando Arroyo; Beomsu Kim; John Yeh
Journal:  Reprod Sci       Date:  2020-01-06       Impact factor: 3.060

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.